2010
DOI: 10.1016/j.virol.2010.06.022
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of monoclonal antibodies specific for the Merkel cell polyomavirus capsid

Abstract: Merkel cell polyomavirus (MCV) has been implicated as a causative agent in Merkel cell carcinoma. Robust polyclonal antibody responses against MCV have been documented in human subjects, but monoclonal antibodies (mAbs) specific for the VP1 capsid protein have not yet been characterized. We generated 12 mAbs capable of binding recombinant MCV virus-like particles. The use of a short immunogenic priming schedule was important for production of the mAbs. Ten of the 12 mAbs were highly effective for immunofluores… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
21
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
8
1

Relationship

4
5

Authors

Journals

citations
Cited by 20 publications
(24 citation statements)
references
References 41 publications
(49 reference statements)
3
21
0
Order By: Relevance
“…Monoclonal antibody Xt7 was raised by priming mice with recombinant HPyV10 sT fused to maltose binding protein followed by boosting with His-tagged recombinant HPyV10 J-domain. Hybridomas were generated and screened as described (15). Validation experiments revealed that Xt7 cross-reacts with the J-domain of a wide variety of polyomavirus LT proteins, including LPV.…”
Section: Methodsmentioning
confidence: 99%
“…Monoclonal antibody Xt7 was raised by priming mice with recombinant HPyV10 sT fused to maltose binding protein followed by boosting with His-tagged recombinant HPyV10 J-domain. Hybridomas were generated and screened as described (15). Validation experiments revealed that Xt7 cross-reacts with the J-domain of a wide variety of polyomavirus LT proteins, including LPV.…”
Section: Methodsmentioning
confidence: 99%
“…Hemagglutination and basement membrane extract experiments used unlabeled capsids, while cell-binding studies used capsids covalently conjugated to Alexa Fluor 488 using previously-reported methods [53]. For production of Alexa Fluor 488 labeled capsids, a reporter plasmid encoding Gaussia luciferase (phGluc; [25]) was included in the initial transfection mixture.…”
Section: Methodsmentioning
confidence: 99%
“…Although one study (25) reports the presence of viral particles by electron microscopy in two of five MCCs, robust antibodies developed against the late capsid protein viral protein 1 (VP1) universally show that tumor cells are negative (26, 27). …”
Section: Merkel Cell Carcinoma and Merkel Cell Polyomavirusmentioning
confidence: 99%